Home › Research › Topics › costs
costs
265 studies tagged costs, dated 1989-11-10 to 2026-10-28. Bibliography: BibTeX (.bib) · RIS (.ris)
Newest in this topic
- The Contribution of Routinely Collected Clinical Data to Dementia Identification in Primary Care: A Cross-Sectional Study 2026-10-28
- Racial Differences and Temporal Trends in Parkinson’s and Alzheimer’s Disease-Related 2026-10-24
- Prognostic heterogeneity within cognitive stages: a nationwide cohort study of everyday functional difficulties and mortality in 202,508 older adults 2026-10-23
Studies
265 studies carry this tag.
Date range
1989 to 2026
Top journals
- Alzheimer's & dementia : the journal of the Alzheimer's Association 38
- Journal of the American Geriatrics Society 21
- medRxiv 19
- Journal of Alzheimer's disease : JAD 15
- Research Square 15
104 journals in all.
Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.
-
Among those newly diagnosed, Black and Hispanic patients encountered higher total costs compared to White patients, and ADRD patients living in the most vulnerable areas experienced the highest total costs compared to patients living in other regions.
-
Overly restrictive clinical trial eligibility criteria can reduce generalizability, slow enrollment, and disproportionately exclude historically underrepresented populations.
-
Participants indicated that they are concerned about cognitive decline, are willing to plan for their future care and cognitive testing, and articulated a desire for Tribally led long-term support services.
-
The analytical sample size of the study was 2,068,937, including 9.9% Black, 82.7% White, and 7.4% Hispanic individuals.
-
AADAPt participants had risk factors for developing dementia in future, such as hypertension and hyperlipidemia, but also reported protective factors such as high social engagement.
-
Dementia is a major health concern in society, particularly in the aging population.
-
These results suggest that prevalence of brain amyloid pathology differed, but that eligibility based on plasma was equally effective across racial and ethnic group members.
-
The burden of neurological disease is increasing globally.
-
Dementia research lacks appropriate representation of diverse groups who often face substantial adversity and greater risk of dementia.
-
Older adults classified with dementia were more likely to drop out of the labor force and become poor than similar older adults without dementia.
-
Most caregivers (72.0%) favored BBBM for AD diagnosis.
-
Reactions to disclosure did not significantly differ among participant groups based on self-reported race and ethnicity.
-
Among 91,881 participants (mean age 59.3 at baseline, 55.0% female participants), 16,507 incident ADRD cases were identified from Medicare claims (1999-2016, mean follow-up 9.3 years).
-
43/100
Significant disparities in symptom severity reported by Alzheimer's caretakers were observed among the racial groups analyzed.
-
1,901 participants completed the MoCA and 547 the HCAP.
-
Among 88 African Americans with cognitive impairment (mean = 10 years follow-up), Medicare claims identified dementia <2 years from cohort diagnosis in 55%; 27% were identified 2-9.9 years after cohort diagnosis, and in 18% there was either no claims diagnosis during the study period, or claims identified dementia 10+ years after cohort diagnosis.
-
59/100
A total number of 450 participants (Mean age = 69.5 years; SD = 10.8) have been screened at different recruitment sites throughout the country, among whom 425 participants (94.4%) met the selection criteria.
-
Included in the analysis were 48,330 participants across 46 ADRCs (mean [SD] age, 71.3 [10.5] years; 20,767 female [57%]; 4,138 Hispanic [8.6%]; 1,392 non-Hispanic Asian [2.9%]; 6,766 non-Hispanic Black [14%] individuals; and 676 individuals [1.4%] of other races.
-
During follow up (mean 11.1 years), 13% of Veterans developed dementia.
-
Twelve of 5536 studies met the inclusion criteria.
-
Adults aged 65+ are at highest risk for severe COVID-19 outcomes, and prior to the distribution of vaccines in the U.S., were strongly advised to quarantine at home to reduce risk of infection.
-
Among 4505 respondents aged ≥70 years, 1750 (38.8%) had possible or probable dementia and 2755 (61.2%) had no dementia.
-
Advance care planning (ACP) can help reduce end-of-life care challenges for persons with Alzheimer's disease and related dementia and their care partners.
-
This study examined the impact of advance care planning (ACP) on healthcare utilization among older adults with normal cognition and impaired cognition/dementia.
-
41/100
Patients with mild AD had higher total costs, patient medical costs, patient social care costs, and family caregiver informal care costs than did patients with MCI; however, only patient medical costs were significantly different (p = 0.022).
-
At ages 50-54, between 79.0% (95% CI: 73.5, 84.5) and 87.6% (95% CI: 84.0, 91.2) of (non-Hispanic) Black, foreign-born Hispanic, and U.S.-born Hispanic women and men remain dual functional as compared with 90.4% (95% CI: 89.3, 91.4) and 91.4% (95% CI: 90.2, 92.5) of (non-Hispanic) White women and men, respectively.
-
With the rapid expansion of the aging population, the burden of Alzheimer's disease related dementias (ADRD) is anticipated to increase in racialized and minoritized groups who are at disproportionately higher risk.
-
Sociodemographic and health characteristics across ethnoracial groups included in the National Alzheimer's Coordinating Center sample (NACC) were compared to the nationally representative Health and Retirement Study (HRS).
-
Alzheimer's disease (AD) and Alzheimer's Disease-Related Dementias (ADRD) are chronic illnesses that are highly prevalent in African Americans (AA).
-
Most PWD (67%) met criteria for another manifestation of serious illness (24% advanced medical condition, 44% ADL impairment).
-
Subjective cognitive decline (SCD), the self-reported experience of worsening or more frequent memory loss or confusion, might be a symptom of early-stage dementia or future serious cognitive decline such as Alzheimer disease* or a related dementia (ADRD) (1).
-
Compared with Non-Hispanic White (NHW) adults, Non-White adults had a higher incidence of AD-specific (hazard ratio [HR] = 2.05, 95% confidence interval [CI]: 1.21, 3.49) and all-cause dementia (HR = 2.01, 95% CI: 1.36, 2.98).
-
Fall rates were higher among PLWD compared to persons without dementia (45.5% vs. 30.9%).
-
When considering race/ethnicity, the presence of more vascular comorbidities drove greater vulnerability.
-
Disparities in incidence of NDD between Black and White beneficiaries narrowed by 0.37 per 100 person-years from 2014 to 2017.
-
Asthma, allergic rhinitis, and atopic dermatitis were significantly associated with increased risk of all-cause dementia and subtypes, with dose-effect relationships with the severity of allergic diseases.
-
The declining incidence of dementia in some countries, despite growing prevalence, is encouraging and urges further investigation.
-
Discrete-time hazard regression results show that sibling loss in mid-to-late life is associated with up to 54% higher risk for dementia.
-
Among newly diagnosed ADRD patients (n = 1299), 26% filled an ADRD prescription ≤90 days and 36% ≤365 days after diagnosis.
-
Of the 286,350 residents in 2019 and the 273,601 in 2020 identified in these cohorts, approximately 31% had a diagnosis of ADRD.
-
In 2019, the global VSL-based economic burden of ADRDs was an estimated $2.8 trillion.
-
Two models comprising behavior change and psychological impact fit well for the total sample and the two racial groups.
-
Recent Medicare claims perform reasonably well in identifying dementia; however, there are consistent differences in cases of dementia identified through claims than in rigorous cohort evaluations.
-
Revised algorithms for dementia diagnosis using Medicare administrative data have reasonable accuracy for research purposes, but investigators should be cognizant of the tradeoffs in accuracy among the approaches they consider.
-
70/100
Our sample included 3,361,950 Medicare enrollees with ADRD (2,156,995 women [64%]; mean [SD] age, 83 [8.0] years; 2,646,405 white [78%], 344,478 black [10%], 224,010 Hispanic [7%]).
-
In total, 6,683 participants were included.
-
Among the diagnosis cohort, mean (SD) overall spending was $4773 ($9774) per quarter - 43% of which was spending on hospital care ($2048).
-
Among 769 randomized dyads, 73% were spousal, 14% adult child, and 13% other dyads.
-
From 2010 to 2016, the incidence and prevalence rates of LBD among Medicare beneficiaries ranged from 0.21%-0.18% and 0.90%-0.83%, respectively.
-
In this study, mental disorders were associated with the onset of dementia in the population.
From across this tag
9 of the 265 studies in this tag, picked by a fixed rule (a hash of each study's address), not by score or date; each page of this list shows a different 9. The same 9 appear here every time.
- Healthy Aging Brain Center improved care coordination and produced net savings
- The transition to retirement and dementia risk: An application of sequence analysis
- Out-of-pocket costs attributable to dementia: A longitudinal analysis
- Characterization of Dementia and Alzheimer’s Disease in an Older Population: Updated Incidence and Life Expectancy With and Without Dementia
- Potentially avoidable hospitalizations among Medicare beneficiaries with Alzheimer's disease and related disorders
- Medicare expenditures attributable to dementia
- Prospective and retrospective memory in normal ageing and dementia: a questionnaire study
- Cognitive screening biases in a secondary prevention Alzheimer’s disease clinical trial
- Association between Internet Use for Health Information and Self-reported Alzheimer’s Disease Diagnosis among Older Adults in the United States: Racial and Gender Disparities